12:11 PM EST - Nextleaf Solutions Ltd : Provides an update on its Specialty Molecules division, specifically the Company's patented novel route of manufacturing D9-tetrahydrocannabinol acetate colloquially referred to as THC-O. Nextleaf has recently produced THC-O under the Company's Health Canada Research Licence in anticipation of commercialization. Nextleaf has validated its manufacturing process of THC-O through third-party analytical
testing. Nextleaf Solutions Ltd
shares C.OILS are trading up 7.7% at $0.07.
